A conversation with David S. Friedman, MD, PhD, on treating uncontrolled open-angle glaucoma in patients with limited options
David S. Friedman, MD, PhD
Advertisement
David S. Friedman, MD, PhD, is the Edith Ives Cogan Professor of Ophthalmology and Director, Glaucoma Services with Massachusetts Eye and Ear at Harvard Medical School in Boston.
Articles by David S. Friedman, MD, PhD
Advertisement
Latest Updated Articles
The Residency Report: Clinical insights from the iStent infinite trialPublished: May 29th 2025 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA clears BVI’s FineVision HP trifocal IOL for the US market
2
Treating myopia today: US-focused treatments, challenges, and global insights
3
US FDA awards Epion Therapeutics EpiSmart cross-linking system Fast Track designation
4
Abeona Therapeutics’ ABO-503 chosen for FDA's Rare Disease Endpoint Advancement Pilot Program
5
.png "Optometry Times"){kind=logo}
